Literature DB >> 18685827

Hyperoncotic colloids in shock and risk of renal injury: enough evidence for a banning order?

Patrick M Honore, Olivier Joannes-Boyau, Willem Boer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18685827     DOI： 10.1007/s00134-008-1226-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  20 in total

1.  Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient.

Authors:  A De Labarthe; F Jacobs; F Blot; D Glotz
Journal:  Am J Med       Date:  2001-10-01       Impact factor: 4.965

2.  Hydroxyethyl starch: does our choice of colloid prevent or add to renal impairment?

Authors:  G H Mills
Journal:  Br J Anaesth       Date:  2007-02       Impact factor: 9.166

3.  Acute renal failure associated with elevated plasma oncotic pressure.

Authors:  M Moran; C Kapsner
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

4.  Acute renal failure precipitated by elevated colloid osmotic pressure.

Authors:  J D Rozich; R V Paul
Journal:  Am J Med       Date:  1989-09       Impact factor: 4.965

5.  [Hydroxyethyl starch-induced transient renal failure in preexisting glomerular damage].

Authors:  P Waldhausen; H Kiesewetter; G Leipnitz; J Scielny; F Jung; R Bambauer; G von Blohn
Journal:  Acta Med Austriaca       Date:  1991

6.  Pathophysiology of protracted acute renal failure in man.

Authors:  S M Moran; B D Myers
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

7.  The risk associated with hyperoncotic colloids in patients with shock.

Authors:  Frédérique Schortgen; Emmanuelle Girou; Nicolas Deye; Laurent Brochard
Journal:  Intensive Care Med       Date:  2008-08-07       Impact factor: 17.440

8.  Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function.

Authors:  Sachin Kheterpal; Kevin K Tremper; Michael J Englesbe; Michael O'Reilly; Amy M Shanks; Douglas M Fetterman; Andrew L Rosenberg; Richard D Swartz
Journal:  Anesthesiology       Date:  2007-12       Impact factor: 7.892

9.  Intensive insulin therapy and pentastarch resuscitation in severe sepsis.

Authors:  Frank M Brunkhorst; Christoph Engel; Frank Bloos; Andreas Meier-Hellmann; Max Ragaller; Norbert Weiler; Onnen Moerer; Matthias Gruendling; Michael Oppert; Stefan Grond; Derk Olthoff; Ulrich Jaschinski; Stefan John; Rolf Rossaint; Tobias Welte; Martin Schaefer; Peter Kern; Evelyn Kuhnt; Michael Kiehntopf; Christiane Hartog; Charles Natanson; Markus Loeffler; Konrad Reinhart
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245

10.  The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment.

Authors:  Cornelius Jungheinrich; Roland Scharpf; Manfred Wargenau; Frank Bepperling; Jean-François Baron
Journal:  Anesth Analg       Date:  2002-09       Impact factor: 5.108
View more
  7 in total

1.  Strong ion gap and outcome after cardiac arrest: another nail in the coffin of traditional acid-base quantification.

Authors:  Patrick M Honore; Olivier Joannes-Boyau; Willem Boer
Journal:  Intensive Care Med       Date:  2008-10-14       Impact factor: 17.440

2.  Small volume resuscitation with 20% albumin in intensive care: physiological effects : The SWIPE randomised clinical trial.

Authors:  Johan Mårtensson; Shailesh Bihari; Jonathan Bannard-Smith; Neil J Glassford; Patryck Lloyd-Donald; Luca Cioccari; Nora Luethi; Aiko Tanaka; Marco Crisman; Nicolas Rey de Castro; Marcus Ottochian; Agnes Huang; Maria Cronhjort; Andrew D Bersten; Shivesh Prakash; Michael Bailey; Glenn M Eastwood; Rinaldo Bellomo
Journal:  Intensive Care Med       Date:  2018-10-21       Impact factor: 17.440

3.  Renal outcomes and mortality following hydroxyethyl starch resuscitation of critically ill patients: systematic review and meta-analysis of randomized trials: ATTENTION: The analysis and conclusions of this article are being revised by the authors. This is due to the journal Anesthesia and Analgesia's retraction of a paper by Dr. Joachim Boldt, an author in seven of the studies analyzed in this review. As such, the editors of Open Medicine recommend interpreting this review with extreme caution until Zarychanski et al. publish a new analysis and interpretation in Open Medicine. For more information, see Anesthesia and Analgesia's press release.

Authors:  Ryan Zarychanski; Alexis F Turgeon; Dean A Fergusson; Deborah J Cook; Paul Hébert; Sean M Bagshaw; Danny Monsour; Lauralyn McIntyre
Journal:  Open Med       Date:  2009-10-27

4.  Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury.

Authors:  Nicolas Boussekey; Raphaël Darmon; Joachim Langlois; Serge Alfandari; Patrick Devos; Agnes Meybeck; Arnaud Chiche; Hugues Georges; Olivier Leroy
Journal:  Crit Care       Date:  2010-03-18       Impact factor: 9.097

5.  To dose or not to dose: that is the (starch) question ...

Authors:  Lewis J Kaplan
Journal:  Crit Care       Date:  2010-05-06       Impact factor: 9.097

Review 6.  PRO: hydroxyethylstarch can be safely used in the intensive care patient--the renal debate.

Authors:  Joachim Boldt
Journal:  Intensive Care Med       Date:  2009-06-17       Impact factor: 17.440

7.  Biomarkers for early diagnosis of AKI in the ICU: ready for prime time use at the bedside?

Authors:  Patrick M Honore; Rita Jacobs; Olivier Joannes-Boyau; Lies Verfaillie; Jouke De Regt; Viola Van Gorp; Elisabeth De Waele; Willem Boer; Vincent Collin; Herbert D Spapen
Journal:  Ann Intensive Care       Date:  2012-07-02       Impact factor: 6.925
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.